New cases come from SEER 12. Deaths come from U.S. Mortality. All Races, Females. Rates are Age-Adjusted. Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software. The 2020 incidence rate is displayed but not used in the fit of the trend line(s). Impact of COVID on SEER Cancer Incidence 2020 data
New cases are also referred to as incident cases in other publications. Rates of new cases are also referred to as incidence rates.
Age-Adjusted Rates of New Cases/Deaths Per 100,000 & 5-Year Relative Survival Percentages
Year
Rate of New Cases — SEER 8
Rate of New Cases — SEER 12
Death Rate — U.S.
5-Year Relative Survival — SEER 8
Observed
Modeled Trend
Observed
Modeled Trend
Observed
Modeled Trend
Observed
Modeled Trend
1975
13.91
14.14
-
-
5.55
5.55
69.80%
70.78%
1976
13.82
13.50
-
-
5.43
5.31
71.65%
70.50%
1977
12.76
12.89
-
-
4.96
5.08
71.75%
70.22%
1978
12.14
12.31
-
-
4.85
4.86
69.61%
69.93%
1979
11.96
11.76
-
-
4.58
4.65
68.71%
69.65%
1980
11.59
11.23
-
-
4.45
4.44
69.81%
69.36%
1981
10.28
10.72
-
-
4.32
4.25
68.02%
69.06%
1982
10.01
10.24
-
-
4.10
4.06
67.42%
68.77%
1983
10.12
10.22
-
-
4.04
4.00
69.00%
68.48%
1984
10.65
10.20
-
-
3.94
3.93
69.91%
68.18%
1985
9.83
10.18
-
-
3.82
3.87
67.49%
67.88%
1986
10.54
10.16
-
-
3.82
3.81
67.28%
67.58%
1987
9.82
10.14
-
-
3.64
3.75
68.44%
69.54%
1988
10.29
10.12
-
-
3.61
3.69
73.08%
71.42%
1989
10.32
10.10
-
-
3.59
3.63
72.28%
73.20%
1990
10.22
10.08
-
-
3.66
3.57
74.01%
73.14%
1991
9.82
10.06
-
-
3.49
3.51
71.16%
73.07%
1992
9.79
10.04
11.06
11.13
3.52
3.45
69.83%
73.00%
1993
9.46
9.73
10.74
10.84
3.41
3.40
73.70%
72.94%
1994
9.42
9.43
10.65
10.56
3.38
3.34
72.73%
72.87%
1995
8.63
9.15
9.87
10.28
3.24
3.29
76.70%
72.81%
1996
9.43
8.86
10.72
10.01
3.21
3.24
75.21%
72.74%
1997
8.85
8.59
9.66
9.75
3.14
3.11
73.06%
72.67%
1998
8.93
8.33
9.79
9.50
2.98
2.99
73.31%
72.61%
1999
8.05
8.07
9.35
9.25
2.83
2.87
75.05%
72.54%
2000
7.43
7.83
8.84
9.00
2.78
2.76
73.74%
72.48%
2001
7.65
7.59
8.65
8.77
2.67
2.65
71.75%
72.41%
2002
7.23
7.35
8.36
8.54
2.55
2.55
70.65%
72.34%
2003
7.13
7.13
8.20
8.32
2.49
2.45
70.87%
72.27%
2004
6.99
6.91
7.85
8.10
2.42
2.44
68.95%
72.21%
2005
6.63
6.70
7.92
7.89
2.42
2.42
68.58%
72.14%
2006
6.83
6.69
7.60
7.68
2.42
2.40
73.36%
72.07%
2007
6.39
6.68
7.37
7.48
2.42
2.39
71.51%
72.01%
2008
6.56
6.67
7.57
7.28
2.37
2.37
73.17%
71.94%
2009
6.70
6.66
7.34
7.09
2.29
2.35
71.28%
71.87%
2010
6.73
6.65
7.25
7.07
2.26
2.34
71.05%
71.80%
2011
6.63
6.64
6.97
7.04
2.33
2.32
70.06%
71.73%
2012
6.58
6.63
7.01
7.02
2.29
2.31
71.13%
71.67%
2013
6.30
6.62
6.64
6.99
2.34
2.29
70.37%
71.60%
2014
6.92
6.61
6.91
6.97
2.27
2.28
72.64%
71.53%
2015
6.79
6.60
6.98
6.94
2.28
2.26
73.97%
71.46%
2016
6.53
6.59
6.91
6.92
2.25
2.25
70.94%
71.39%
2017
6.41
6.58
6.74
6.89
2.25
2.23
-
71.32%
2018
6.68
6.57
7.15
6.87
2.19
2.22
-
71.25%
2019
6.46
6.56
6.75
6.84
2.17
2.20
-
71.19%
2020
6.01
6.55
6.25
6.82
2.22
2.19
-
71.12%
2021
6.57
6.54
6.87
6.79
2.28
2.17
-
71.05%
2022
-
-
-
-
2.07
2.16
-
70.98%
Rate of New Cases and Deaths per 100,000: The rate of new cases of cervical cancer was 7.6 per 100,000 women per year. The death rate was 2.2 per 100,000 women per year. These rates are age-adjusted and based on 2017–2021 cases and 2018–2022 deaths.
Lifetime Risk of Developing Cancer: Approximately 0.6 percent of women will be diagnosed with cervical cancer at some point during their lifetime, based on 2018–2021 data, excluding 2020 due to COVID.
Prevalence of This Cancer: In 2021, there were an estimated 295,748 women living with cervical cancer in the United States.
Did You Know? Video Series
Did You Know? Video Series
How Many People Survive 5 Years Or More after Being Diagnosed with Cervical Cancer?
Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It excludes the risk of dying from other causes. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.
5-Year Relative Survival
67.4%
Based on data from SEER 22 (Excluding IL/MA) 2014–2020. Gray figures represent those who have died from cervical cancer. Green figures represent those who have survived 5 years or more.
Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. The earlier cervical cancer is caught, the better chance a person has of surviving five years after being diagnosed. For cervical cancer, 42.0% are diagnosed at the local stage. The 5-year relative survival for localized cervical cancer is 91.1%.
Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Cervical Cancer
Stage
Percent of Cases
5-Year Relative Survival
Localized Confined to Primary Site
42%
91.1%
Regional Spread to Regional Lymph Nodes
36%
60.8%
Distant Cancer Has Metastasized
15%
19.4%
Unknown Unstaged
6%
61.4%
Percent of Cases by Stage
Localized (42%) Confined to Primary Site
Regional (36%) Spread to Regional Lymph Nodes
Distant (15%) Cancer Has Metastasized
Unknown (6%) Unstaged
5-Year Relative Survival
SEER 22 (Excluding IL/MA) 2014–2020, All Races, Females by SEER Combined Summary Stage
Compared to other cancers, cervical cancer is relatively rare.
Rank
Common Types of Cancer
Estimated New Cases 2024
Estimated Deaths 2024
1.
Breast Cancer (Female)
310,720
42,250
2.
Prostate Cancer
299,010
35,250
3.
Lung and Bronchus Cancer
234,580
125,070
4.
Colorectal Cancer
152,810
53,010
5.
Melanoma of the Skin
100,640
8,290
6.
Bladder Cancer
83,190
16,840
7.
Kidney and Renal Pelvis Cancer
81,610
14,390
8.
Non-Hodgkin Lymphoma
80,620
20,140
9.
Uterine Cancer
67,880
13,250
10.
Pancreatic Cancer
66,440
51,750
-
-
-
20.
Cervical Cancer
13,820
4,360
Cervical cancer represents 0.7% of all new cancer cases in the U.S.
0.7%
In 2024, it is estimated that there will be 13,820 new cases of cervical cancer and an estimated 4,360 people will die of this disease.
Who Gets This Cancer?
Infection of the cervix with human papillomavirus (HPV) is the most common cause of cervical cancer, although not all women with HPV infection will develop cervical cancer. The rate of new cases of cervical cancer was 7.6 per 100,000 women per year based on 2017–2021 cases, age-adjusted.
Rate of New Cases per 100,000 Persons by Race/Ethnicity: Cervical Cancer
Males
All Races
Sex-specific cancer type
Hispanic
Non-Hispanic American Indian/Alaska Native
Non-Hispanic Asian/Pacific Islander
Non-Hispanic Black
Non-Hispanic White
Females
All Races
7.6
Hispanic
9.8
Non-Hispanic American Indian/Alaska Native
9.2
Non-Hispanic Asian/Pacific Islander
6.1
Non-Hispanic Black
8.7
Non-Hispanic White
6.9
All Races
Hispanic
Non-Hispanic American Indian/ Alaska Native
Non-Hispanic Asian / Pacific Islander
Non-Hispanic Black
Non-Hispanic White
SEER 22 2017–2021, Age-Adjusted
Percent of New Cases by Age Group: Cervical Cancer
Age Range
Percent of New Cases
<20
0.1%
20–34
13.8%
35–44
24.3%
45–54
21.6%
55–64
19.0%
65–74
12.5%
75–84
6.3%
>84
2.4%
Cervical cancer is most frequently diagnosed among women aged 35–44.
Median Age At Diagnosis
50
SEER 22 2017–2021, All Races, Females
Who Dies From This Cancer?
The death rate was 2.2 per 100,000 women per year based on 2018–2022, age-adjusted.
Death Rate per 100,000 Persons by Race/Ethnicity: Cervical Cancer
Males
All Races
Sex-specific cancer type
Hispanic
Non-Hispanic American Indian/Alaska Native
Non-Hispanic Asian/Pacific Islander
Non-Hispanic Black
Non-Hispanic White
Females
All Races
2.2
Hispanic
2.4
Non-Hispanic American Indian/Alaska Native
3.0
Non-Hispanic Asian/Pacific Islander
1.6
Non-Hispanic Black
3.2
Non-Hispanic White
2.1
All Races
Hispanic
Non-Hispanic American Indian/ Alaska Native
Non-Hispanic Asian / Pacific Islander
Non-Hispanic Black
Non-Hispanic White
U.S. 2018–2022, Age-Adjusted
Percent of Deaths by Age Group: Cervical Cancer
Age Range
Percent of Deaths
<20
0.0%
20–34
4.8%
35–44
13.8%
45–54
20.0%
55–64
23.5%
65–74
19.8%
75–84
11.8%
>84
6.2%
The percent of cervical cancer deaths is highest among women aged 55–64.
Median Age At Death
59
U.S. 2018–2022, All Races, Females
Changes Over Time
Keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.
Using statistical models for analysis, age-adjusted rates for new cervical cancer cases have been stable over 2012–2021. Age-adjusted death rates have been falling on average 0.7% each year over 2013–2022. 5-year relative survival trends are shown below.
New Cases, Deaths and 5-Year Relative Survival
Rate of New Cases
Death Rate
New cases come from SEER 8. Deaths come from U.S. Mortality. All Races, Females. Rates are Age-Adjusted. Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software. The 2020 incidence rate is displayed but not used in the fit of the trend line(s). Impact of COVID on SEER Cancer Incidence 2020 data
5-Year Relative Survival
SEER 8 5-Year Relative Survival Percent from 1975–2016, All Races, Females. Modeled trend lines were calculated from the underlying rates using the Joinpoint Survival Model Software.
With SEER*Explorer, you can...
Create custom graphs and tables
Download data and images
Share links to results
SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by sex, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.
Figure: Anatomy of the female reproductive system; drawing shows the uterus, myometrium (muscular outer layer of the uterus), endometrium (inner lining of the uterus), ovaries, fallopian tubes, cervix, and vagina.
Figure: Female Reproductive Anatomy
Figure: Anatomy of the female reproductive system; drawing shows the uterus, myometrium (muscular outer layer of the uterus), endometrium (inner lining of the uterus), ovaries, fallopian tubes, cervix, and vagina.
This cancer forms in tissues of the cervix (the organ connecting the uterus and vagina). It is usually a slow-growing cancer that may not have symptoms but can be found with regular Pap tests (a procedure in which cells are scraped from the cervix and looked at under a microscope). Cervical cancer is almost always caused by human papillomavirus (HPV) infection.
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within SEER*Explorer.
Suggested Citation
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse SEER*Explorer. To see statistics for a specific state, go to the State Cancer Profiles.
The statistics presented in these stat facts are based on the most recent data available, most of which can be found in SEER*Explorer. In some cases, different year spans may be used.
Estimates of new cases and deaths for 2024 are projections made by the American Cancer Society (ACS), based on earlier reported data.
Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.
An official website of the United States government
Localized (42%)
Regional (36%)
Distant (15%)
Unknown (6%)
